GB1135783A - Heparin and heparinoid compositions - Google Patents

Heparin and heparinoid compositions

Info

Publication number
GB1135783A
GB1135783A GB2237766A GB2237766A GB1135783A GB 1135783 A GB1135783 A GB 1135783A GB 2237766 A GB2237766 A GB 2237766A GB 2237766 A GB2237766 A GB 2237766A GB 1135783 A GB1135783 A GB 1135783A
Authority
GB
United Kingdom
Prior art keywords
heparin
compositions
heparinoid
carbon atoms
sulphone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2237766A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maple Leaf Foods Inc
Original Assignee
Canada Packers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canada Packers Inc filed Critical Canada Packers Inc
Publication of GB1135783A publication Critical patent/GB1135783A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,135,783. Anticoagulants. CANADA PACKERS Ltd. 19 May, 1966 [20 May, 1965], No. 22377/66. Heading ASB. Anticoagulant compositions suitable for oral administration comprise heparin, or a heparinoid e.g. heparitin sulphate (heparin monosulphuric acid), or dextran sulphate in combination with at least one non-toxic physiologically acceptable absorption-enhancing sulphone having the formula R 1 R 2 SO 2 wherein R 1 and R 2 are selected from (a) alkyl and alkenyl of up to 12 carbon atoms; (b) aralkyl; (c) a cyclic structure wherein R 1 and R 2 together with the sulphur atom form a ring containing 4 or 5 carbon atoms. Examples of suitable sulphones include diethyl and di-n-propyl sulphone and sulpholane and sulpholene and their homologues and close analogues e.g. wherein one or more of the hydrogen atoms may be substituted by hydrocarbon radicals. The compositions may also contain water and may be in the form of a solution or suspension, or preferably may be encapsulated in a gelatin capsule which is enteric coated.
GB2237766A 1965-05-20 1966-05-19 Heparin and heparinoid compositions Expired GB1135783A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45750265A 1965-05-20 1965-05-20

Publications (1)

Publication Number Publication Date
GB1135783A true GB1135783A (en) 1968-12-04

Family

ID=23816992

Family Applications (2)

Application Number Title Priority Date Filing Date
GB2237766A Expired GB1135783A (en) 1965-05-20 1966-05-19 Heparin and heparinoid compositions
GB2237866A Expired GB1135784A (en) 1965-05-20 1966-05-19 Improved heparin and heparinoid compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2237866A Expired GB1135784A (en) 1965-05-20 1966-05-19 Improved heparin and heparinoid compositions

Country Status (1)

Country Link
GB (2) GB1135783A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546338A (en) * 1967-03-30 1970-12-08 American Cyanamid Co Heparin composition
DE3032462A1 (en) * 1979-08-30 1981-03-19 Robert J. Camas Wash. Herschler PREPARATIONS FOR USE ON OR IN TISSUE AND / OR LIQUIDS OF THE HUMAN OR ANIMAL BODY

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546338A (en) * 1967-03-30 1970-12-08 American Cyanamid Co Heparin composition
DE3032462A1 (en) * 1979-08-30 1981-03-19 Robert J. Camas Wash. Herschler PREPARATIONS FOR USE ON OR IN TISSUE AND / OR LIQUIDS OF THE HUMAN OR ANIMAL BODY

Also Published As

Publication number Publication date
GB1135784A (en) 1968-12-04

Similar Documents

Publication Publication Date Title
GB1495970A (en) Flame retardant polycarbonate composition
ES8801643A1 (en) Pharmaceutical compositions containing ascorbic acid derivatives.
GB1496680A (en) Flame retardant polycarbonate composition
GB1135783A (en) Heparin and heparinoid compositions
KR830007079A (en) Bone Injectable Radiopharmaceuticals and Nonradioactive Carriers thereof
ES439927A1 (en) 7-Methoxy-6-thiatetracyclines and their preparation
KR880013557A (en) New Ophthalmic Compositions
SE7310986L (en) PROCEDURE FOR PREPARING THE SUBJECT LEMPLIGA SASOM TOYS.
SE8203053L (en) CYSTEIN DERIVATIVES IN THE FORM OF DISULFID
GB1493684A (en) S-substituted-2-thiodenosines
GB1424341A (en) Diketoesters
GB1145934A (en) Access for the preparation of pyrazinoyl- and pyrazinamido-guanidines
ES432439A1 (en) Xanthene and thioxanthene derivatives, compositions thereof and a method of preparation thereof
GB1292556A (en) Sulfonamides and their acylates
GB1336983A (en) Sulphonyl-ureas and sulphonyl-semicarbazides
JPS5770820A (en) Immunoregulating agent
SU682446A1 (en) Method of the autoclave melting-off of sulphur
GB1152421A (en) A process of preventing inflammation of trialkyl boranes
FI824061A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA 3 '' '- DEHYDRO-CARDENOLIDES-TRIDIGITOXOSIDOXIMER OCH ANVAENDNING DEM SOM CEILING MODEL
ES445343A1 (en) Quaternary xanthinylalkyl nortropine
BE890116A (en) DERIVATIVES OF AMINOTHIOLS, THEIR PREPARATION AND USE AS WELL AS COMPOSITIONS CONTAINING THESE DERIVATIVES
MY102276A (en) Antimykotische aminoazole i
SE8404560L (en) CLEAN UP COMPOSITION
ES418331A1 (en) Quinoline derivatives processes for their preparation and compo sitions incorporating them
FI824062L (en) FOERFARANDE FOER FRAMSTAELLNING AV KETALER AV NYA 3 '' '- DEHYDRO-CARDENOLIDES-TRIDIGITOXOSIDER OCH ANVAENDNING AV DEM SOM CEILING MODEL